Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Celgene Corp (NASDAQ:CELG)

During the Trading Day
119.58 +4.12 / +3.57%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
119.58 0.00 / 0.00%
Volume: 241.7K
Biotech Stock Roundup: Amgen in the News, ARIAD a Takeover Target?
9:41am / Zacks.com
Manic Markets: Healthcare Bargains Worth Buying
Aug 28 / MotleyFool.com
'Mad Money' Lightning Round: Forget Omeros, Buy Celgene
8:08am / TheStreet.com
How China's Troubles Affect Biotech and Pharma Stocks: Part 2
Aug 27 / TheStreet.com
Jim Cramer's Top Takeaways: Celgene, Facebook, Zoe's Kitchen
8:08am / TheStreet.com
How China's Troubles Affect Biotech and Pharma Stocks: Part 1
Aug 27 / TheStreet.com
Jim Cramer's 'Mad Money' Recap: We've Bounced Back Before and Will Again
8:08am / TheStreet.com
10 Reasons Why It's So Easy to Fall in Love With Celgene
Aug 26 / MotleyFool.com
Here's What the Managers of the $9 Billion TIAA-CREF Trust Have Been Selling
Sep 01 / MotleyFool.com
Bouncing Biotech? 3 Stocks To Buy
Aug 25 / MotleyFool.com
Think Stocks Are Tough? Try a Fantasy Draft
Sep 01 / TheStreet.com
Why Acorda Therapeutics, Inc. Stock Surged Higher Today
Aug 25 / MotleyFool.com
Cramer's Takes on Celgene, Qorvo, Boston Scientific and Many More
Sep 01 / TheStreet.com
US 'big four' biotechs lead sector tumble into bear market
Aug 24 / FT.com
Cramer: Ignore the Short-Term Noise, Stick With High-Quality Stocks
Sep 01 / TheStreet.com
The Stock Market Is Tumbling: 3 Actions to Take & 3 Stocks to Consider Buying
Aug 21 / MotleyFool.com
CELG, PFE, REGN, RCPT Jim Cramer's Views
Aug 31 / TheStreet.com
3 Best Stocks for Your Kid's College Fund
Aug 20 / MotleyFool.com
The Future Is ... OK; What You Can Trust, and What You Can't: Jim Cramer's Best Blogs
Aug 28 / TheStreet.com
3 Biotech Stocks We Love
Aug 20 / MotleyFool.com
6 Big Lessons to Learn from this Monumental Market Week
Aug 28 / TheStreet.com
Bill Gates joins $120m fundraising for Editas Medicine gene start-up
Aug 10 / FT.com